Sarepta Therapeutics Inc
NASDAQ:SRPT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sarepta Therapeutics Inc
NASDAQ:SRPT
|
US |
|
D
|
DXC Technology Co
F:2XT
|
US |
|
K
|
Kiatnakin Phatra Bank PCL
SET:KKP
|
TH |
|
F
|
F5 Inc
XMUN:FFV
|
US |
|
B
|
Biogen Inc
XMUN:IDP
|
US |
|
M
|
MLP SE
XMUN:MLP
|
DE |
|
P
|
Panasonic Holdings Corp
XMUN:MAT1
|
JP |
|
Bandwidth Inc
NASDAQ:BAND
|
US |
Wall St Price Targets
SRPT Price Targets Summary
Sarepta Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for SRPT is 22.82 USD with a low forecast of 5.05 USD and a high forecast of 39.9 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SRPT's stock price target?
Price Target
22.82
USD
According to Wall Street analysts, the average 1-year price target for SRPT is 22.82 USD with a low forecast of 5.05 USD and a high forecast of 39.9 USD.
What is the Revenue forecast for Sarepta Therapeutics Inc?
Projected CAGR
-4%
Over the last 13 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 8 years is -4%.
What is the Gross Profit forecast for Sarepta Therapeutics Inc?
Projected CAGR
-2%
The compound annual growth rate for Gross Profit over the next 8 years is -2%.
